Marianne Vandenhende

Suggest Changes
Learn More
BACKGROUND Current clinical guidelines consider regimens consisting of either ritonavir-boosted atazanavir or ritonavir-boosted lopinavir and a nucleoside reverse transcriptase inhibitor (NRTI)(More)